切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Autophagy - M4 Receptors - ErbB - Voltage-gated Sodium (NaV) Channels

21件产品中的 11-20

页面
每页
清除全部
  1. A-803467
    B2277 A-803467
    Target: Voltage-gated Sodium (NaV) Channels
    Summary: NaV1.8通道阻断剂
      ≥13.95 mg/mL
      insoluble in H2O
  2. Chloroquine diphosphate
    A8628 Chloroquine diphosphate
     1 Citation
    中文名: 二磷酸氯喹
    Target: Autophagy
    Summary: 抗疟疾药物,TLR7和TLR9抑制剂
      insoluble in DMSO
      ≥106.06 mg/mL
  3. Riluzole
    A8513 Riluzole
    中文名: 力鲁唑
    Target: Voltage-gated Sodium (NaV) Channels|glutamate release
    Summary: 钠通道抑制剂
      ≥23.4 mg/mL
      insoluble in H2O
  4. AZD8931 (Sapitinib)
    A8375 AZD8931 (Sapitinib)
    中文名: 沙普替尼
    Target: EGFR|ErbB
    Summary: ErbB抑制剂
      ≥23.7 mg/mL
      insoluble in H2O
  5. Atropine sulfate monohydrate
    A8369 Atropine sulfate monohydrate
    中文名: 硫酸阿托品一水合物
    Target: M3 Receptors|M1 Receptors|M2 Receptors|M4 Receptors|M5 Receptors
    Summary: MAChRs拮抗剂
      ≥34.74 mg/mL
      ≥56.5 mg/mL
  6. Dacomitinib (PF299804, PF299)
    A8319 Dacomitinib (PF299804, PF299)
    中文名: 达克替尼
    Target: ErbB
    Summary: HER抑制剂
      ≥23.5 mg/mL
      insoluble in H2O
  7. Zonisamide
    A5354 Zonisamide
    中文名: 唑尼沙胺
    Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Carbonic Anhydrases|Calcium-Activated Potassium (KCa) Channels
    Summary: 抗惊厥和机械效应的抗癫痫药
      ≥8.35 mg/mL
      insoluble in H2O
  8. Lapatinib
    A8218 Lapatinib
     2 Citation
    中文名: 拉帕替尼
    Target: ErbB
    Summary: EGFR/HER2抑制剂
      ≥29.05 mg/mL
      insoluble in H2O
  9. Pifithrin-μ
    A4482 Pifithrin-μ
     1 Citation
    Target: Autophagy|p53|HSP70
    Summary: p53结合抑制剂,抗凋亡。
      ≥18.1 mg/mL
      insoluble in H2O
  10. Flecainide acetate
    A3418 Flecainide acetate
    中文名: 氟卡胺
    Target: Voltage-gated Sodium (NaV) Channels
    Summary: 抗心律失常药
      ≥47.4 mg/mL
      ≥23.7 mg/mL

21件产品中的 11-20

页面
每页